Etcembly's TCR therapeutics featured in Forbes

AI expert and futurist Bernard Marr has written about Etcembly's innovative generative AI approach to developing TCR-based cancer therapeutics in Forbes - Breakthrough In Cancer Treatment: The Role Of Generative AI In Drug Development